• レポートコード:MMG23DC16261 • 出版社/出版日:Market Monitor Global / 2023年12月 • レポート形態:英語、PDF、74ページ • 納品方法:Eメール(受注後2-3営業日) • 産業分類:医療機器&消耗品 |
Single User(1名様閲覧用) | ¥487,500 (USD3,250) | ▷ お問い合わせ |
Multi User(20名様閲覧用) | ¥633,750 (USD4,225) | ▷ お問い合わせ |
Enterprise User(閲覧人数制限なし) | ¥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートは次の情報を含め、世界の非侵襲性神経調節デバイス市場規模と予測を収録しています。・世界の非侵襲性神経調節デバイス市場:売上、2018年-2023年、2024年-2029年 ・世界の非侵襲性神経調節デバイス市場:販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の非侵襲性神経調節デバイス市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経皮的眼窩上神経刺激」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 非侵襲性神経調節デバイスのグローバル主要企業は、Neuroelectrics、 Aneuvo、 Soterix Medical、 Magstim、 BrainsWay、 ElectroCore Medical、 NeuroCare Group、 Koninklijke Philips、 NESA World、 DEYMED Diagnostic、 electroCore、 Medistar、 Vagustimなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL(MMG)は、非侵襲性神経調節デバイスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の非侵襲性神経調節デバイス市場:タイプ別、2018年-2023年、2024年-2029年 世界の非侵襲性神経調節デバイス市場:タイプ別市場シェア、2022年 ・経皮的眼窩上神経刺激、シングルパルス経頭蓋磁気刺激、非侵襲的迷走神経刺激、その他 世界の非侵襲性神経調節デバイス市場:用途別、2018年-2023年、2024年-2029年 世界の非侵襲性神経調節デバイス市場:用途別市場シェア、2022年 ・病院&クリニック、認知症ケアセンター、研究機関、その他 世界の非侵襲性神経調節デバイス市場:地域・国別、2018年-2023年、2024年-2029年 世界の非侵襲性神経調節デバイス市場:地域別市場シェア、2022年 ・北米:アメリカ、カナダ、メキシコ ・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア ・アジア:中国、日本、韓国、東南アジア、インド ・南米:ブラジル、アルゼンチン ・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における非侵襲性神経調節デバイスのグローバル売上、2018年-2023年 ・主要企業における非侵襲性神経調節デバイスのグローバル売上シェア、2022年 ・主要企業における非侵襲性神経調節デバイスのグローバル販売量、2018年-2023年 ・主要企業における非侵襲性神経調節デバイスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Neuroelectrics、 Aneuvo、 Soterix Medical、 Magstim、 BrainsWay、 ElectroCore Medical、 NeuroCare Group、 Koninklijke Philips、 NESA World、 DEYMED Diagnostic、 electroCore、 Medistar、 Vagustim ************************************************************* ・調査・分析レポートの概要 非侵襲性神経調節デバイス市場の定義 市場セグメント 世界の非侵襲性神経調節デバイス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の非侵襲性神経調節デバイス市場規模 世界の非侵襲性神経調節デバイス市場規模:2022年 VS 2029年 世界の非侵襲性神経調節デバイス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの非侵襲性神経調節デバイスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の非侵襲性神経調節デバイス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分:経皮的眼窩上神経刺激、シングルパルス経頭蓋磁気刺激、非侵襲的迷走神経刺激、その他 非侵襲性神経調節デバイスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分:病院&クリニック、認知症ケアセンター、研究機関、その他 非侵襲性神経調節デバイスの用途別グローバル売上・予測 ・地域別市場分析 地域別非侵襲性神経調節デバイス市場規模 2022年と2029年 地域別非侵襲性神経調節デバイス売上・予測 北米市場:アメリカ、カナダ、メキシコ ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア アジア市場:中国、日本、韓国、東南アジア、インド 南米市場:ブラジル、アルゼンチン 中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど) Neuroelectrics、 Aneuvo、 Soterix Medical、 Magstim、 BrainsWay、 ElectroCore Medical、 NeuroCare Group、 Koninklijke Philips、 NESA World、 DEYMED Diagnostic、 electroCore、 Medistar、 Vagustim ... |
This research report provides a comprehensive analysis of the Non-Invasive Neuromodulatory Devices market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Non-Invasive Neuromodulatory Devices market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Non-Invasive Neuromodulatory Devices, challenges faced by the industry, and potential opportunities for market players.
The global Non-Invasive Neuromodulatory Devices market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Non-Invasive Neuromodulatory Devices market presents opportunities for various stakeholders, including Hospitals & Clinics, Cognitive Care Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Non-Invasive Neuromodulatory Devices market. Additionally, the growing consumer demand present avenues for market expansion.
The global Non-Invasive Neuromodulatory Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Non-Invasive Neuromodulatory Devices market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Non-Invasive Neuromodulatory Devices market.
Market Overview: The report provides a comprehensive overview of the Non-Invasive Neuromodulatory Devices market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Transcutaneous Supraorbital Neurostimulation, Single-Pulse Transcranial Magnetic Stimulation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Non-Invasive Neuromodulatory Devices market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Non-Invasive Neuromodulatory Devices market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Non-Invasive Neuromodulatory Devices market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Non-Invasive Neuromodulatory Devices market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Non-Invasive Neuromodulatory Devices market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Non-Invasive Neuromodulatory Devices market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Non-Invasive Neuromodulatory Devices, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Non-Invasive Neuromodulatory Devices market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Non-Invasive Neuromodulatory Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Transcutaneous Supraorbital Neurostimulation
Single-Pulse Transcranial Magnetic Stimulation
Non-invasive Vagal Nerve Stimulation
Others
Market segment by Application
Hospitals & Clinics
Cognitive Care Centers
Research Institutes
Others
Global Non-Invasive Neuromodulatory Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Neuroelectrics
Aneuvo
Soterix Medical
Magstim
BrainsWay
ElectroCore Medical
NeuroCare Group
Koninklijke Philips
NESA World
DEYMED Diagnostic
electroCore
Medistar
Vagustim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Invasive Neuromodulatory Devices, market overview.
Chapter 2: Global Non-Invasive Neuromodulatory Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Non-Invasive Neuromodulatory Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Invasive Neuromodulatory Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-Invasive Neuromodulatory Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Non-Invasive Neuromodulatory Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Invasive Neuromodulatory Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Invasive Neuromodulatory Devices Overall Market Size
2.1 Global Non-Invasive Neuromodulatory Devices Market Size: 2022 VS 2029
2.2 Global Non-Invasive Neuromodulatory Devices Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-Invasive Neuromodulatory Devices Sales: 2018-2029
3 Company Landscape
3.1 Top Non-Invasive Neuromodulatory Devices Players in Global Market
3.2 Top Global Non-Invasive Neuromodulatory Devices Companies Ranked by Revenue
3.3 Global Non-Invasive Neuromodulatory Devices Revenue by Companies
3.4 Global Non-Invasive Neuromodulatory Devices Sales by Companies
3.5 Global Non-Invasive Neuromodulatory Devices Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-Invasive Neuromodulatory Devices Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-Invasive Neuromodulatory Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-Invasive Neuromodulatory Devices Players in Global Market
3.8.1 List of Global Tier 1 Non-Invasive Neuromodulatory Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-Invasive Neuromodulatory Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-Invasive Neuromodulatory Devices Market Size Markets, 2022 & 2029
4.1.2 Transcutaneous Supraorbital Neurostimulation
4.1.3 Single-Pulse Transcranial Magnetic Stimulation
4.1.4 Non-invasive Vagal Nerve Stimulation
4.1.5 Others
4.2 By Type – Global Non-Invasive Neuromodulatory Devices Revenue & Forecasts
4.2.1 By Type – Global Non-Invasive Neuromodulatory Devices Revenue, 2018-2023
4.2.2 By Type – Global Non-Invasive Neuromodulatory Devices Revenue, 2024-2029
4.2.3 By Type – Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
4.3 By Type – Global Non-Invasive Neuromodulatory Devices Sales & Forecasts
4.3.1 By Type – Global Non-Invasive Neuromodulatory Devices Sales, 2018-2023
4.3.2 By Type – Global Non-Invasive Neuromodulatory Devices Sales, 2024-2029
4.3.3 By Type – Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
4.4 By Type – Global Non-Invasive Neuromodulatory Devices Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-Invasive Neuromodulatory Devices Market Size, 2022 & 2029
5.1.2 Hospitals & Clinics
5.1.3 Cognitive Care Centers
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application – Global Non-Invasive Neuromodulatory Devices Revenue & Forecasts
5.2.1 By Application – Global Non-Invasive Neuromodulatory Devices Revenue, 2018-2023
5.2.2 By Application – Global Non-Invasive Neuromodulatory Devices Revenue, 2024-2029
5.2.3 By Application – Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
5.3 By Application – Global Non-Invasive Neuromodulatory Devices Sales & Forecasts
5.3.1 By Application – Global Non-Invasive Neuromodulatory Devices Sales, 2018-2023
5.3.2 By Application – Global Non-Invasive Neuromodulatory Devices Sales, 2024-2029
5.3.3 By Application – Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
5.4 By Application – Global Non-Invasive Neuromodulatory Devices Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Non-Invasive Neuromodulatory Devices Market Size, 2022 & 2029
6.2 By Region – Global Non-Invasive Neuromodulatory Devices Revenue & Forecasts
6.2.1 By Region – Global Non-Invasive Neuromodulatory Devices Revenue, 2018-2023
6.2.2 By Region – Global Non-Invasive Neuromodulatory Devices Revenue, 2024-2029
6.2.3 By Region – Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
6.3 By Region – Global Non-Invasive Neuromodulatory Devices Sales & Forecasts
6.3.1 By Region – Global Non-Invasive Neuromodulatory Devices Sales, 2018-2023
6.3.2 By Region – Global Non-Invasive Neuromodulatory Devices Sales, 2024-2029
6.3.3 By Region – Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.4.2 By Country – North America Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.4.3 US Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.4.4 Canada Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.4.5 Mexico Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.5.2 By Country – Europe Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.5.3 Germany Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.4 France Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.5 U.K. Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.6 Italy Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.7 Russia Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.8 Nordic Countries Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.5.9 Benelux Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.6.2 By Region – Asia Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.6.3 China Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.4 Japan Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.5 South Korea Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.6 Southeast Asia Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.6.7 India Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.7.2 By Country – South America Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.7.3 Brazil Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.7.4 Argentina Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Non-Invasive Neuromodulatory Devices Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Non-Invasive Neuromodulatory Devices Sales, 2018-2029
6.8.3 Turkey Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8.4 Israel Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8.5 Saudi Arabia Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
6.8.6 UAE Non-Invasive Neuromodulatory Devices Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Neuroelectrics
7.1.1 Neuroelectrics Company Summary
7.1.2 Neuroelectrics Business Overview
7.1.3 Neuroelectrics Non-Invasive Neuromodulatory Devices Major Product Offerings
7.1.4 Neuroelectrics Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.1.5 Neuroelectrics Key News & Latest Developments
7.2 Aneuvo
7.2.1 Aneuvo Company Summary
7.2.2 Aneuvo Business Overview
7.2.3 Aneuvo Non-Invasive Neuromodulatory Devices Major Product Offerings
7.2.4 Aneuvo Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.2.5 Aneuvo Key News & Latest Developments
7.3 Soterix Medical
7.3.1 Soterix Medical Company Summary
7.3.2 Soterix Medical Business Overview
7.3.3 Soterix Medical Non-Invasive Neuromodulatory Devices Major Product Offerings
7.3.4 Soterix Medical Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.3.5 Soterix Medical Key News & Latest Developments
7.4 Magstim
7.4.1 Magstim Company Summary
7.4.2 Magstim Business Overview
7.4.3 Magstim Non-Invasive Neuromodulatory Devices Major Product Offerings
7.4.4 Magstim Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.4.5 Magstim Key News & Latest Developments
7.5 BrainsWay
7.5.1 BrainsWay Company Summary
7.5.2 BrainsWay Business Overview
7.5.3 BrainsWay Non-Invasive Neuromodulatory Devices Major Product Offerings
7.5.4 BrainsWay Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.5.5 BrainsWay Key News & Latest Developments
7.6 ElectroCore Medical
7.6.1 ElectroCore Medical Company Summary
7.6.2 ElectroCore Medical Business Overview
7.6.3 ElectroCore Medical Non-Invasive Neuromodulatory Devices Major Product Offerings
7.6.4 ElectroCore Medical Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.6.5 ElectroCore Medical Key News & Latest Developments
7.7 NeuroCare Group
7.7.1 NeuroCare Group Company Summary
7.7.2 NeuroCare Group Business Overview
7.7.3 NeuroCare Group Non-Invasive Neuromodulatory Devices Major Product Offerings
7.7.4 NeuroCare Group Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.7.5 NeuroCare Group Key News & Latest Developments
7.8 Koninklijke Philips
7.8.1 Koninklijke Philips Company Summary
7.8.2 Koninklijke Philips Business Overview
7.8.3 Koninklijke Philips Non-Invasive Neuromodulatory Devices Major Product Offerings
7.8.4 Koninklijke Philips Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.8.5 Koninklijke Philips Key News & Latest Developments
7.9 NESA World
7.9.1 NESA World Company Summary
7.9.2 NESA World Business Overview
7.9.3 NESA World Non-Invasive Neuromodulatory Devices Major Product Offerings
7.9.4 NESA World Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.9.5 NESA World Key News & Latest Developments
7.10 DEYMED Diagnostic
7.10.1 DEYMED Diagnostic Company Summary
7.10.2 DEYMED Diagnostic Business Overview
7.10.3 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Major Product Offerings
7.10.4 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.10.5 DEYMED Diagnostic Key News & Latest Developments
7.11 electroCore
7.11.1 electroCore Company Summary
7.11.2 electroCore Business Overview
7.11.3 electroCore Non-Invasive Neuromodulatory Devices Major Product Offerings
7.11.4 electroCore Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.11.5 electroCore Key News & Latest Developments
7.12 Medistar
7.12.1 Medistar Company Summary
7.12.2 Medistar Business Overview
7.12.3 Medistar Non-Invasive Neuromodulatory Devices Major Product Offerings
7.12.4 Medistar Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.12.5 Medistar Key News & Latest Developments
7.13 Vagustim
7.13.1 Vagustim Company Summary
7.13.2 Vagustim Business Overview
7.13.3 Vagustim Non-Invasive Neuromodulatory Devices Major Product Offerings
7.13.4 Vagustim Non-Invasive Neuromodulatory Devices Sales and Revenue in Global (2018-2023)
7.13.5 Vagustim Key News & Latest Developments
8 Global Non-Invasive Neuromodulatory Devices Production Capacity, Analysis
8.1 Global Non-Invasive Neuromodulatory Devices Production Capacity, 2018-2029
8.2 Non-Invasive Neuromodulatory Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-Invasive Neuromodulatory Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-Invasive Neuromodulatory Devices Supply Chain Analysis
10.1 Non-Invasive Neuromodulatory Devices Industry Value Chain
10.2 Non-Invasive Neuromodulatory Devices Upstream Market
10.3 Non-Invasive Neuromodulatory Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-Invasive Neuromodulatory Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Non-Invasive Neuromodulatory Devices in Global Market
Table 2. Top Non-Invasive Neuromodulatory Devices Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-Invasive Neuromodulatory Devices Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-Invasive Neuromodulatory Devices Revenue Share by Companies, 2018-2023
Table 5. Global Non-Invasive Neuromodulatory Devices Sales by Companies, (Units), 2018-2023
Table 6. Global Non-Invasive Neuromodulatory Devices Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-Invasive Neuromodulatory Devices Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Non-Invasive Neuromodulatory Devices Product Type
Table 9. List of Global Tier 1 Non-Invasive Neuromodulatory Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Invasive Neuromodulatory Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Non-Invasive Neuromodulatory Devices Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-Invasive Neuromodulatory Devices Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Non-Invasive Neuromodulatory Devices Sales (Units), 2018-2023
Table 15. By Type - Global Non-Invasive Neuromodulatory Devices Sales (Units), 2024-2029
Table 16. By Application – Global Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Non-Invasive Neuromodulatory Devices Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-Invasive Neuromodulatory Devices Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Non-Invasive Neuromodulatory Devices Sales (Units), 2018-2023
Table 20. By Application - Global Non-Invasive Neuromodulatory Devices Sales (Units), 2024-2029
Table 21. By Region – Global Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Non-Invasive Neuromodulatory Devices Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-Invasive Neuromodulatory Devices Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Non-Invasive Neuromodulatory Devices Sales (Units), 2018-2023
Table 25. By Region - Global Non-Invasive Neuromodulatory Devices Sales (Units), 2024-2029
Table 26. By Country - North America Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Non-Invasive Neuromodulatory Devices Sales, (Units), 2018-2023
Table 29. By Country - North America Non-Invasive Neuromodulatory Devices Sales, (Units), 2024-2029
Table 30. By Country - Europe Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Non-Invasive Neuromodulatory Devices Sales, (Units), 2018-2023
Table 33. By Country - Europe Non-Invasive Neuromodulatory Devices Sales, (Units), 2024-2029
Table 34. By Region - Asia Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Non-Invasive Neuromodulatory Devices Sales, (Units), 2018-2023
Table 37. By Region - Asia Non-Invasive Neuromodulatory Devices Sales, (Units), 2024-2029
Table 38. By Country - South America Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Non-Invasive Neuromodulatory Devices Sales, (Units), 2018-2023
Table 41. By Country - South America Non-Invasive Neuromodulatory Devices Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Non-Invasive Neuromodulatory Devices Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Non-Invasive Neuromodulatory Devices Sales, (Units), 2024-2029
Table 46. Neuroelectrics Company Summary
Table 47. Neuroelectrics Non-Invasive Neuromodulatory Devices Product Offerings
Table 48. Neuroelectrics Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Neuroelectrics Key News & Latest Developments
Table 50. Aneuvo Company Summary
Table 51. Aneuvo Non-Invasive Neuromodulatory Devices Product Offerings
Table 52. Aneuvo Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Aneuvo Key News & Latest Developments
Table 54. Soterix Medical Company Summary
Table 55. Soterix Medical Non-Invasive Neuromodulatory Devices Product Offerings
Table 56. Soterix Medical Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Soterix Medical Key News & Latest Developments
Table 58. Magstim Company Summary
Table 59. Magstim Non-Invasive Neuromodulatory Devices Product Offerings
Table 60. Magstim Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Magstim Key News & Latest Developments
Table 62. BrainsWay Company Summary
Table 63. BrainsWay Non-Invasive Neuromodulatory Devices Product Offerings
Table 64. BrainsWay Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. BrainsWay Key News & Latest Developments
Table 66. ElectroCore Medical Company Summary
Table 67. ElectroCore Medical Non-Invasive Neuromodulatory Devices Product Offerings
Table 68. ElectroCore Medical Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. ElectroCore Medical Key News & Latest Developments
Table 70. NeuroCare Group Company Summary
Table 71. NeuroCare Group Non-Invasive Neuromodulatory Devices Product Offerings
Table 72. NeuroCare Group Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. NeuroCare Group Key News & Latest Developments
Table 74. Koninklijke Philips Company Summary
Table 75. Koninklijke Philips Non-Invasive Neuromodulatory Devices Product Offerings
Table 76. Koninklijke Philips Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Koninklijke Philips Key News & Latest Developments
Table 78. NESA World Company Summary
Table 79. NESA World Non-Invasive Neuromodulatory Devices Product Offerings
Table 80. NESA World Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. NESA World Key News & Latest Developments
Table 82. DEYMED Diagnostic Company Summary
Table 83. DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Product Offerings
Table 84. DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. DEYMED Diagnostic Key News & Latest Developments
Table 86. electroCore Company Summary
Table 87. electroCore Non-Invasive Neuromodulatory Devices Product Offerings
Table 88. electroCore Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. electroCore Key News & Latest Developments
Table 90. Medistar Company Summary
Table 91. Medistar Non-Invasive Neuromodulatory Devices Product Offerings
Table 92. Medistar Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Medistar Key News & Latest Developments
Table 94. Vagustim Company Summary
Table 95. Vagustim Non-Invasive Neuromodulatory Devices Product Offerings
Table 96. Vagustim Non-Invasive Neuromodulatory Devices Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Vagustim Key News & Latest Developments
Table 98. Non-Invasive Neuromodulatory Devices Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 99. Global Non-Invasive Neuromodulatory Devices Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Non-Invasive Neuromodulatory Devices Production by Region, 2018-2023 (Units)
Table 101. Global Non-Invasive Neuromodulatory Devices Production by Region, 2024-2029 (Units)
Table 102. Non-Invasive Neuromodulatory Devices Market Opportunities & Trends in Global Market
Table 103. Non-Invasive Neuromodulatory Devices Market Drivers in Global Market
Table 104. Non-Invasive Neuromodulatory Devices Market Restraints in Global Market
Table 105. Non-Invasive Neuromodulatory Devices Raw Materials
Table 106. Non-Invasive Neuromodulatory Devices Raw Materials Suppliers in Global Market
Table 107. Typical Non-Invasive Neuromodulatory Devices Downstream
Table 108. Non-Invasive Neuromodulatory Devices Downstream Clients in Global Market
Table 109. Non-Invasive Neuromodulatory Devices Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-Invasive Neuromodulatory Devices Segment by Type in 2022
Figure 2. Non-Invasive Neuromodulatory Devices Segment by Application in 2022
Figure 3. Global Non-Invasive Neuromodulatory Devices Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-Invasive Neuromodulatory Devices Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-Invasive Neuromodulatory Devices Revenue, 2018-2029 (US$, Mn)
Figure 7. Non-Invasive Neuromodulatory Devices Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-Invasive Neuromodulatory Devices Revenue in 2022
Figure 9. By Type - Global Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 11. By Type - Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 12. By Type - Global Non-Invasive Neuromodulatory Devices Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 15. By Application - Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 16. By Application - Global Non-Invasive Neuromodulatory Devices Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 20. By Region - Global Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 21. By Country - North America Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 22. By Country - North America Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 23. US Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 28. Germany Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 29. France Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 37. China Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 41. India Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 43. By Country - South America Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 44. Brazil Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Non-Invasive Neuromodulatory Devices Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Non-Invasive Neuromodulatory Devices Sales Market Share, 2018-2029
Figure 48. Turkey Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Non-Invasive Neuromodulatory Devices Revenue, (US$, Mn), 2018-2029
Figure 52. Global Non-Invasive Neuromodulatory Devices Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Non-Invasive Neuromodulatory Devices by Region, 2022 VS 2029
Figure 54. Non-Invasive Neuromodulatory Devices Industry Value Chain
Figure 55. Marketing Channels